Skip to main content
    P

    PetMed Express Inc (PETS)

    Official site

    HEALTHCARE • PHARMACEUTICAL RETAILERS • NASDAQ

    $0.90
    +0.00 (+0.20%)

    Market Cap: $19.96M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    PetMed Express Inc (PETS) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    PetMed Express (PETS) has a market cap of $19.96M and an enterprise value of $8.54M. It holds $11.42M more cash than debt, 57.21% of its market cap. Revenue fell 19.17% over the last 12 months from the 12 months before.

    Total Valuation

    Enterprise value is 57.21% below the market cap, as cash exceeds debt.

    Market Cap$19.96M
    Enterprise Value$8.54M
    Latest price (Nov 17, 2026)$0.90

    Key Dates

    The next earnings report is expected on Feb 3, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 3, 2027 (expected)
    Last Earnings DateNov 10, 2026
    Fiscal Year EndMarch

    Share Statistics

    The share count fell 2.81% in the quarter ended Sep 30, 2026 and grew 1.11% a year over 3 years.

    Shares Outstanding21.07M
    Shares Change (YoY)+0.88%
    Shares Change (QoQ)-2.81%
    Share Count Growth (3Y CAGR)+1.11%

    Valuation Ratios

    Sales and book value multiples are 0.1x and 1.1x. Its year-end P/S ranged from 0.4x to 3.4x from 2016 to 2024.

    P/S Ratio0.1x
    P/B Ratio1.1x
    P/TBV Ratio2.9x

    Valuation history and multiples

    Price Statistics

    The stock is down 55.02% over 52 weeks and trades 31.30% below its 50-day average.

    Beta (1Y)0.89
    52-Week Change-55.02%
    1-Month Change-21.78%
    3-Month Change-49.18%
    6-Month Change-59.30%
    5-Year Change-95.81%
    10-Year Change-94.01%
    Total Return (1Y)-55.02%
    Total Return (3Y CAGR)-50.94%
    Total Return (5Y CAGR)-49.11%
    Max Drawdown (1Y)-76.98%
    Max Drawdown (3Y)-88.37%
    Sharpe Ratio (1Y)-0.93
    Correlation with SPY (1Y)0.16
    50-Day Average$1.31
    200-Day Average$1.98
    52-Week Range$0.85 to $4.10
    RSI (14 Days)19.8
    Average Volume (20 Days)121.80K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 0.60x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio0.60x
    Quick Ratio0.45x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -161.27% over the last 12 months, against a 5-year average of -38.64%.

    Return on Equity (ROE)-161.27%
    Return on Assets (ROA)-45.78%
    ROE (5Y Average)-38.64%
    ROA (5Y Average)-13.14%
    Asset Turnover2.01x
    Inventory Turnover15.67x
    Receivables Turnover104.10x
    Cash Conversion Cycle-17 days

    Scores

    PETS has an Altman Z-Score of 1.00, in the distress zone below 1.81, and a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.

    Altman Z-Score1.00
    Altman Z ZoneDistress
    Piotroski F-Score2 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $160.26M over the last 12 months.

    Revenue$160.26M
    Revenue Growth (YoY)-19.17%
    Gross Profit$44.53M
    Operating Income-$28.81M
    Pretax Income-$27.26M
    Net Income-$27.19M
    EBITDA-$18.60M
    Reported EPS (TTM)-$1.28

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 28.38% of the $59.40M in total assets.

    Cash and Equivalents$11.42M
    Total Debt$0
    Net Cash$11.42M
    Net Cash Per Share$0.54
    Working Capital-$17.02M
    Shareholder Equity$16.86M
    Book Value Per Share$0.80
    Tangible Book Value$6.55M
    Tangible Book Per Share$0.31
    Total Assets$59.40M
    Total Liabilities$42.54M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $1.97M of capital spending, operating cash flow left -$24.66M of free cash flow.

    Operating Cash Flow-$22.69M
    Capital Expenditures$1.97M
    Free Cash Flow-$24.66M
    FCF Per Share-$1.14
    Depreciation and Amortization$9.16M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -17.98%, against a 5-year average of -5.01%.

    Gross Margin27.79%
    Operating Margin-17.98%
    Pretax Margin-17.01%
    Net Margin-16.97%
    EBITDA Margin-11.61%
    FCF Margin-15.39%
    Gross Margin (5Y Average)29.72%
    Operating Margin (5Y Average)-5.01%
    Net Margin (5Y Average)-5.71%

    Growth

    Revenue fell 10.24% a year over 3 years.

    Revenue Growth (3Y CAGR)-10.24%
    Revenue Growth (5Y CAGR)-10.02%

    Revenue and profit by year

    Peer Position

    Against 8 similar companies, PETS has the lowest P/S.

    P/S Ratio0.1x vs 4.4x median
    Revenue Growth (Trailing 4 Quarters, YoY)-19.17% vs +246.13% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at -7.70% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)-7.70%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About PETS

    What is PETS's market cap?

    PetMed Express has a market cap of $19.96M. Its enterprise value, which adds debt and subtracts cash, is $8.54M.

    How many shares of PETS are outstanding?

    PetMed Express has 21.07M shares outstanding. The count is up 0.88% from a year earlier.

    Does PETS pay a dividend?

    No. PetMed Express does not pay a dividend.

    How much debt does PETS have?

    PetMed Express has $0 of total debt and $11.42M of cash and equivalents, a net cash position of $11.42M.